LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | XMD16-144 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5393 | 5505 | 0.9797 | 0.9709 |
BT-20 | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5266 | 5505 | 0.9565 | 0.9377 |
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5689 | 5505 | 1.0334 | 1.0477 |
BT-20 | BX-912 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5063 | 5505 | 0.9197 | 0.8851 |
BT-20 | NVP-AEW541 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5806 | 5505 | 1.0547 | 1.0782 |
BT-20 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5376 | 5505 | 0.9765 | 0.9663 |
BT-20 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5524 | 5505 | 1.0034 | 1.0049 |
BT-20 | PIK-93 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5721 | 5505 | 1.0392 | 1.0560 |
BT-20 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5546 | 5505 | 1.0074 | 1.0106 |
BT-20 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5207 | 5505 | 0.9459 | 0.9226 |
BT-20 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5939 | 5505 | 1.0788 | 1.1127 |
BT-20 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4615 | 5505 | 0.8384 | 0.7687 |
BT-20 | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4869 | 5505 | 0.8844 | 0.8345 |
BT-20 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5156 | 5505 | 0.9365 | 0.9091 |
BT-20 | Luminespib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 1802 | 5505 | 0.3273 | 0.0375 |
BT-20 | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4715 | 5505 | 0.8565 | 0.7947 |
BT-20 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1657 | 6123 | 5505 | 1.1122 | 1.1605 |
BT-20 | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4819 | 5505 | 0.8753 | 0.8216 |
BT-20 | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5724 | 5505 | 1.0397 | 1.0568 |
BT-20 | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5736 | 5505 | 1.0419 | 1.0599 |
BT-20 | Dactolisib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 2762 | 5505 | 0.5017 | 0.2870 |
BT-20 | AZD-6482 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5328 | 5505 | 0.9679 | 0.9540 |
BT-20 | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 1657 | 2646 | 5505 | 0.4806 | 0.2568 |
BT-20 | WH-4-025 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5402 | 5505 | 0.9813 | 0.9732 |
BT-20 | TGX221 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5249 | 5505 | 0.9534 | 0.9334 |